Company Filing History:
Years Active: 1999
Title: Angus George Dalgleish: Innovator in Immunomodulatory Compounds
Introduction
Angus George Dalgleish is an accomplished inventor based in Cheam, GB. He is currently associated with Celgene Corporation, where he focuses on groundbreaking research in the field of immunomodulatory compounds. Despite having no granted patents to his name, his contributions to the scientific community are noteworthy.
Latest Patent Applications
Dalgleish's latest patent applications include significant advancements in cancer treatment. One application titled "Immunomodulatory Compounds for the Restoration of Vitamin D Sensitivity in Vitamin D Resistant Tumor Cells" outlines methods for restoring vitamin D sensitivity in resistant tumor cells. This application also discusses the use of immunomodulatory compounds in combination with vitamin D agents for treating, preventing, or managing cancer. Another application, "Immunological Uses of Immunomodulatory Compounds for Vaccine and Anti-Infectious Disease Therapy," reveals methods to enhance immune response to immunogens and reduce sensitivity to allergens through specific dosing regimens of immunomodulatory compounds.
Conclusion
Angus George Dalgleish is a dedicated inventor whose work in immunomodulatory compounds holds promise for advancing cancer treatment and enhancing immune responses. His innovative research continues to contribute to the field of medicine.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.